To download the full report, click here.

The 340B program was originally created in 1992 to help safety-net facilities, like clinics and hospitals, that serve a large number of vulnerable or uninsured patients. The program requires pharmaceutical manufacturers to provide steep discounts to these facilities as a condition of their medicines being covered by Medicaid. Today, however, the 340B program bears little resemblance to what Congress envisioned.